Literature DB >> 7094975

Transfer of mepindolol to newborns by breast-feeding mothers after single and repeated daily doses.

W Krause, I Stoppelli, S Milia, E Rainer.   

Abstract

The concentrations of mepindolol in plasma and milk of five breastfeeding mothers were determined after 1 and 5 daily doses of mepindolol sulphate 20 mg. In the newborns plasma levels were measured once on the first and fifth days of the study. The mean maternal plasma concentration of mepindolol 2 h after administration was 52 ng/ml both after 1 and 5 doses; in the milk 18 and 22 ng/ml the corresponding concentrations were. The average plasma/milk drug concentration ratio was 2.6 +/- 1.6. Plasma levels in the newborn were below the detection limit of 1 ng/ml, except for one baby in whom 2 and 5 ng/ml, respectively, were found 4 h after one and five maternal doses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094975     DOI: 10.1007/BF00606425

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Nadolol: placental transfer and excretion in the milk of rats.

Authors:  J Dreyfuss; J M Shaw; T J Miller
Journal:  Toxicol Appl Pharmacol       Date:  1977-02       Impact factor: 4.219

2.  Pharmacokinetics of a new beta-adrenoceptor blocking agent, LF 17-895, in man.

Authors:  R Gugler; L Kreis; H J Dengler
Journal:  Arzneimittelforschung       Date:  1975-07

3.  Elimination kinetics of amobarbital in mothers and their newborn infants.

Authors:  B Krauer; G H Draffan; F M Williams; R A Clare; C T Dollery; D F Hawkins
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

4.  Excretion of chlorothiazide in human breast milk.

Authors:  M W Werthmann; S V Krees
Journal:  J Pediatr       Date:  1972-10       Impact factor: 4.406

5.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

6.  Update: drugs in breast milk.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1979-03-09       Impact factor: 1.909

7.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.

Authors:  W H Aellig
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

Review 9.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

10.  Determination of plasma mepindolol levels by high-performance liquid chromatography and electrochemical detection.

Authors:  W Krause
Journal:  J Chromatogr       Date:  1980-01-11
View more
  2 in total

Review 1.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.